Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection
Open Access
- 1 March 1998
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 351 (9105), 786-792
- https://doi.org/10.1016/s0140-6736(97)06532-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1997
- Control Strategies for Tuberculosis Epidemics: New Models for Old ProblemsScience, 1996
- Surveillance of drug resistance for tuberculosis control: Why and how?Tubercle and Lung Disease, 1995
- Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Côte dʼlvoireAIDS, 1995
- A prospective study of the risk of tuberculosis among HIV-infected patientsAIDS, 1993
- Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infectionThe Lancet, 1993
- Influence of Tuberculosis on Human Immunodeficiency Virus (HIV-1): Enhanced Cytokine Expression and Elevated 2-Microglobulin in HIV-1-Associated TuberculosisThe Journal of Infectious Diseases, 1993
- Tuberculosis and HIV Infection in Sub-Saharan AfricaPublished by American Medical Association (AMA) ,1992
- Tuberculin Skin Test Reactivity among Adults Infected with Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1992
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989